Maria E. Navas

418 total citations
18 papers, 280 citations indexed

About

Maria E. Navas is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Clinical Biochemistry. According to data from OpenAlex, Maria E. Navas has authored 18 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Clinical Biochemistry. Recurrent topics in Maria E. Navas's work include Bacterial Identification and Susceptibility Testing (5 papers), Infection Control and Ventilation (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Maria E. Navas is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Infection Control and Ventilation (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Maria E. Navas collaborates with scholars based in United States and Colombia. Maria E. Navas's co-authors include Gary W. Procop, Trina F. Zabarsky, Curtis J. Donskey, Linda Sercia, Sandra S. Richter, Donald A. Wilson, Geraldine S. Hall, Marion J. Tuohy, Christina Wojewoda and Jennifer L. Cadnum and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Maria E. Navas

17 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria E. Navas United States 9 122 93 81 78 58 18 280
Metka Paragi Slovenia 9 154 1.3× 7 0.1× 57 0.7× 160 2.1× 37 0.6× 23 353
Adrian R Tramontana Australia 7 237 1.9× 18 0.2× 21 0.3× 367 4.7× 49 0.8× 12 468
Jane Mikhail United Kingdom 8 57 0.5× 65 0.7× 23 0.3× 66 0.8× 37 0.6× 9 306
Jesús Ruiz-Aragón Spain 11 92 0.8× 28 0.3× 47 0.6× 176 2.3× 41 0.7× 40 315
Michael D. Nowak United States 7 244 2.0× 5 0.1× 28 0.3× 133 1.7× 19 0.3× 21 363
Helen S. Bond Hong Kong 8 162 1.3× 17 0.2× 12 0.1× 124 1.6× 18 0.3× 9 299
Marie-Céline Zanella Switzerland 11 127 1.0× 16 0.2× 9 0.1× 128 1.6× 16 0.3× 31 285
Ralph Tayyar United States 8 99 0.8× 14 0.2× 15 0.2× 139 1.8× 30 0.5× 18 246
Jack Davis United States 9 139 1.1× 13 0.1× 26 0.3× 68 0.9× 12 0.2× 12 252
Muna Al Maslamani Qatar 10 171 1.4× 5 0.1× 21 0.3× 130 1.7× 20 0.3× 33 314

Countries citing papers authored by Maria E. Navas

Since Specialization
Citations

This map shows the geographic impact of Maria E. Navas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. Navas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. Navas more than expected).

Fields of papers citing papers by Maria E. Navas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria E. Navas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. Navas. The network helps show where Maria E. Navas may publish in the future.

Co-authorship network of co-authors of Maria E. Navas

This figure shows the co-authorship network connecting the top 25 collaborators of Maria E. Navas. A scholar is included among the top collaborators of Maria E. Navas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria E. Navas. Maria E. Navas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Anderson, Neil, et al.. (2024). Approaches to developing and implementing a molecular diagnostics stewardship program for infectious diseases: an ASM Laboratory Practices Subcommittee report. Journal of Clinical Microbiology. 62(11). e0094124–e0094124. 2 indexed citations
2.
O’Brien, Timothy D., Kirsten M Boughan, Maria E. Navas, & M. Qasim Ansari. (2023). M-Protein Analysis Test: Effects of Combining Serum Protein Electrophoresis and Free Light Chain Assay Tests into One Order. Blood. 142(Supplement 1). 6759–6759.
3.
Lee, Grace, et al.. (2023). NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade. Frontiers in Immunology. 14. 1022890–1022890. 7 indexed citations
5.
Chan, E. Ricky, Jennifer L. Cadnum, Sarah N. Redmond, et al.. (2022). Investigation of a cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in a hospital administration building. Infection Control and Hospital Epidemiology. 44(2). 277–283. 6 indexed citations
6.
Saad, Anas M., et al.. (2022). Antimicrobial Susceptibility Profile of Aerococcus urinae: Recommendations for Empirical Therapy. Infectious Diseases in Clinical Practice. 31(1). 1 indexed citations
7.
Jinadatha, Chetan, Hosoon Choi, Piyali Chatterjee, et al.. (2021). Transmission of SARS-CoV-2 in Inpatient and Outpatient Settings in a Veterans Affairs Health Care System. Open Forum Infectious Diseases. 8(8). ofab328–ofab328. 21 indexed citations
8.
Chan, E. Ricky, Sarah N. Redmond, Maria E. Navas, et al.. (2021). Use of whole-genome sequencing to investigate a cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in emergency department personnel. Infection Control and Hospital Epidemiology. 43(10). 1485–1487. 20 indexed citations
9.
Redmond, Sarah N., Navid Sadri, Christine Schmotzer, et al.. (2021). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated and unvaccinated healthcare personnel in a Veterans’ Affairs healthcare system. Infection Control and Hospital Epidemiology. 43(9). 1300–1301. 4 indexed citations
10.
Chan, E. Ricky, Trina F. Zabarsky, Jennifer L. Cadnum, et al.. (2021). Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Patient Transport Van. Clinical Infectious Diseases. 74(2). 339–342. 21 indexed citations
11.
Zabarsky, Trina F., et al.. (2020). What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection?. American Journal of Infection Control. 49(3). 392–395. 36 indexed citations
12.
Redmond, Sarah N., Khalid M Dousa, Jennifer L. Cadnum, et al.. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid contamination of surfaces on a coronavirus disease 2019 (COVID-19) ward and intensive care unit. Infection Control and Hospital Epidemiology. 42(2). 215–217. 13 indexed citations
13.
Patel, Sachin, Maria E. Navas, Courtney E. Batt, & Robin Jump. (2016). Oral Cryptococcosis in a Patient with Chronic Lymphocytic Leukemia. International Journal of Infectious Diseases. 50. 18–20. 5 indexed citations
14.
Navas, Maria E., Robin Jump, David H. Canaday, et al.. (2016). Can anaerobes be acid fast? A novel, clinically relevant acid fast anaerobe. JMM Case Reports. 3(4). e005036–e005036. 8 indexed citations
15.
Navas, Maria E., David Pincus, Linda Sercia, et al.. (2014). Identification of Aerobic Gram-Positive Bacilli by Use of Vitek MS. Journal of Clinical Microbiology. 52(4). 1274–1277. 15 indexed citations
16.
Wojewoda, Christina, Linda Sercia, Maria E. Navas, et al.. (2013). Evaluation of the Verigene Gram-Positive Blood Culture Nucleic Acid Test for Rapid Detection of Bacteria and Resistance Determinants. Journal of Clinical Microbiology. 51(7). 2072–2076. 89 indexed citations
17.
Navas, Maria E., et al.. (2013). A Case of Endocarditis Caused by Lactococcus garvieae and Suggested Methods for Identification. Journal of Clinical Microbiology. 51(6). 1990–1992. 25 indexed citations
18.
Navas, Maria E., et al.. (2012). State of the art of emerging technologies in Colombia. Portland International Conference on Management of Engineering and Technology. 358–367. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026